Susan Kahn - 21 Dec 2021 Form 4 Insider Report for LogicBio Therapeutics, Inc.

Role
Director
Signature
/s/ Andrea Paul, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Dec 2021
Net transactions value
$0
Form type
4
Filing time
23 Dec 2021, 08:14:30 UTC
Next filing
21 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LOGC Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 21 Dec 2021 Common Stock 25,000 $2.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted pursuant to the Issuer's non-employee director compensation policy in connection with the Reporting Person's appointment as a member of the Issuer's Board of Directors. The options will vest over three years as follows: one third (1/3) of the shares underlying the options will vest on each of the first, second and third anniversaries of the grant date.